Israel Cancer Research Fund (ICRF) - Montreal

Fund-raising - Westmount, Quebec, Canada

Israel Cancer Research Fund (ICRF) - Montreal Employees
Stu Guttman

Chief Executive Officer

Contact Stu Guttman

Contact All Israel Cancer Research Fund (ICRF) - Montreal Employees
Israel Cancer Research Fund (ICRF) - Montreal Senior Management
Stu Guttman

Chief Executive Officer

Contact Stu Guttman

Contact All Israel Cancer Research Fund (ICRF) - Montreal Employees
Israel Cancer Research Fund (ICRF) - Montreal Details

OUR MISSION Founded in 1975, ICRF is a non profit organization consisting of physicians, scientists and volunteers who are dedicated to supporting innovative cancer research in Israel and locally in Montreal. Together we can find a cure!Since its inception, ICRF has raised more than $68 million and has funded over 2400 cancer research projects. A scientific advisory board consisting of internationally renowned cancer specialists stringently review grant applications – only those applicants deemed most worthy are selected.ICRF has offices in Montreal, Toronto, Connecticut, New York, Chicago, Los Angeles, Miami and Israel. The Montreal chapter represents an integral part of the ICRF family and to date the per capita funding raised by this group has been greater than any other chapter. During the past few years we have made significant strides in the search for a cure and continue to be determined to achieve.WHAT WE'VE ACHIEVEDp53: A Key Tumor Suppressor that Prevents Tumor Growth – this is one of the most important discoveries of the 20th century and has inspired cancer researchers around the world. Many cancer researchers now consider the p53 gene to be a possible key to the cure for cancer.The Philadelphia Chromosome – this is the first genetic link to cancer ever discovered and has led to the development of Gleevec®, a miracle drug for the treatment of chronic myelogynous leukemia. Gleevec® is now used by over 100,000 people worldwide.Doxil®: A Drug Used in the Treatment of Breast, Ovarian and AIDS-related Cancers. Doxil directs drugs to the diseased tissues only, not to the rest of the patient's body and releases them slowly. This greatly reduces the side effects normally associated with chemotherapy. The impact of Doxil on the efficacy and safety of treatment of advanced ovarian and breast cancer is already evident in the clinical practice.& MUCH MORE!

Israel Cancer Research Fund (ICRF) - Montreal logo, Israel Cancer Research Fund (ICRF) - Montreal contact details
Employees: 1
HQ: +1 514-481-2723
Location: Westmount, Quebec, Canada
Revenue:
Israel Cancer Research Fund (ICRF) - Montreal Technologies
Email Providers

Outlook

Fonts

Typekit

Email Delivery

Postmark

Other

Mobile Friendly

Online Video Platforms

YouTube

View All Technologies Used At Israel Cancer Research Fund (ICRF) - Montreal

Contacting Israel Cancer Research Fund (ICRF) - Montreal: Connect with Executives and Employees

Get in Touch with Israel Cancer Research Fund (ICRF) - Montreal Executives and Employees

Connecting with Israel Cancer Research Fund (ICRF) - Montreal's Executives and Workforce

Accessing Contact Information for Israel Cancer Research Fund (ICRF) - Montreal Executives

Connecting with Israel Cancer Research Fund (ICRF) - Montreal: Reach Out to Their Team

Discover How to Contact Israel Cancer Research Fund (ICRF) - Montreal Executives and Staff

Looking to connect with Israel Cancer Research Fund (ICRF) - Montreal executives or employees?

Seeking to Get in Touch with Israel Cancer Research Fund (ICRF) - Montreal Executives or Staff?

Want to Reach Out to Israel Cancer Research Fund (ICRF) - Montreal Executives or Team Members?

In Search of Contact Details for Israel Cancer Research Fund (ICRF) - Montreal Professionals?

Connecting with Israel Cancer Research Fund (ICRF) - Montreal: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z